Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Recepto (Q47816484)
Jump to navigation
Jump to search
scientific article published in July 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Recepto |
scientific article published in July 1998 |
Statements
1 reference
Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Recepto (English)
1 reference
1 reference
A M Lincoff
1 reference
D J Kereiakes
1 reference
R A Califf
1 reference
S Ghaffari
1 reference
T A Kelly
1 reference
G C Timmis
1 reference
N S Kleiman
1 reference
J J Ferguson
1 reference
D P Miller
1 reference
1 July 1998
1 reference
1 reference
82
1 reference
1
1 reference
7-12
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference